InvestorsHub Logo
Followers 14
Posts 1572
Boards Moderated 0
Alias Born 06/14/2018

Re: jobynimble post# 34072

Thursday, 07/27/2023 3:39:52 PM

Thursday, July 27, 2023 3:39:52 PM

Post# of 34846
I got a Benzinga report from TD Ameritrade.
"6:15 am ET June 29, 2023 (Benzinga)
AlloVir
The Trade: AlloVir, Inc. (NASDAQ: ALVR) 10% owner Gilead Sciences Inc acquired a total 2,930,870 shares an average price of $3.75. To acquire these shares, it cost around $10.99 million.
What’s Happening: AlloVir priced a 20 million share offering at $3.75 per share."

P.S. I'm guessing that others believed enough to buy the other 17+ million shares of the offering at $3.75.
P.P.S. I'm holding MRKR and NOT selling even one share. If it drops more I'll buy more but I would REALLY like the stategic review first before I do.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News